These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6427069)

  • 1. Development and evaluation of the improved iron chelating agents EHPG, HBED and their dimethyl esters.
    Hershko C; Grady RW; Link G
    Haematologia (Budap); 1984; 17(1):25-33. PubMed ID: 6427069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenolic ethylenediamine derivatives: a study of orally effective iron chelators.
    Hershko C; Grady RW; Link G
    J Lab Clin Med; 1984 Mar; 103(3):337-46. PubMed ID: 6699459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of iron-chelating agents in an in vivo system: potential usefulness of EHPG, a powerful iron-chelating drug.
    Hershko C; Grady RW; Link G
    Br J Haematol; 1982 Jun; 51(2):251-60. PubMed ID: 7082583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UV and fluorescence spectral changes induced by neodymium binding of N,N'-ethylenebis[2-(o-hydroxyphenolic)glycine] and N,N'-di(2-hydroxybenzyl)ethylenediamine-N,N' diacetic acid.
    Wang Z; Yang B
    Spectrochim Acta A Mol Biomol Spectrosc; 2006 Nov; 65(3-4):946-9. PubMed ID: 16684618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of iron removal from the reticuloendothelial system by liposome encapsulation of N,N'-bis[2-hydroxybenzyl]-ethylenediamine-N,N'-diacetic acid (HBED). Comparison with desferrioxamine.
    Lau EH; Cerny EA; Wright BJ; Rahman YE
    J Lab Clin Med; 1983 May; 101(5):806-16. PubMed ID: 6403640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical evaluation of HBED/Fe(3+) and the novel HJB/Fe(3+) chelates as fertilizers to alleviate iron chlorosis.
    López-Rayo S; Hernández D; Lucena JJ
    J Agric Food Chem; 2009 Sep; 57(18):8504-13. PubMed ID: 19689133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Fe-HBED and Fe-EHPG as hepatobiliary MR contrast agents.
    Hoener B; Engelstad BL; Ramos EC; Macapinlac HA; Price DC; Johnson TR; White DL
    J Magn Reson Imaging; 1991; 1(3):357-62. PubMed ID: 1802149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimalarial effect of HBED and other phenolic and catecholic iron chelators.
    Yinnon AM; Theanacho EN; Grady RW; Spira DT; Hershko C
    Blood; 1989 Nov; 74(6):2166-71. PubMed ID: 2508794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectral studies on the interaction of yttrium ion with the ligands of phenolic groups: N,N'-Ethylenebis[2-(o-hydroxyphenolic)glycine] and N,N'-di(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid.
    Duan L; Zhao YQ; Yang BS
    Spectrochim Acta A Mol Biomol Spectrosc; 2007 Sep; 68(1):165-8. PubMed ID: 17267267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBED: A potential alternative to deferoxamine for iron-chelating therapy.
    Bergeron RJ; Wiegand J; Brittenham GM
    Blood; 1998 Feb; 91(4):1446-52. PubMed ID: 9454776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBED: the continuing development of a potential alternative to deferoxamine for iron-chelating therapy.
    Bergeron RJ; Wiegand J; Brittenham GM
    Blood; 1999 Jan; 93(1):370-5. PubMed ID: 9864183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenolic aminocarboxylic acids as gallium-binding radiopharmaceuticals.
    Hunt FC
    Nuklearmedizin; 1984 Jun; 23(3):123-5. PubMed ID: 6435093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel double prodrugs of the iron chelator N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid (HBED): Synthesis, characterization, and investigation of activation by chemical hydrolysis and oxidation.
    Thiele NA; Abboud KA; Sloan KB
    Eur J Med Chem; 2016 Aug; 118():193-207. PubMed ID: 27128183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBED ligand: preclinical studies of a potential alternative to deferoxamine for treatment of chronic iron overload and acute iron poisoning.
    Bergeron RJ; Wiegand J; Brittenham GM
    Blood; 2002 Apr; 99(8):3019-26. PubMed ID: 11929795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of physicochemical and in-vivo behavior of diastereomeric iron-59, gallium-68, and indium-111-EHPG trivalent metal complexes.
    Madsen SL; Bannochie CJ; Martell AE; Mathias CJ; Welch MJ
    J Nucl Med; 1990 Oct; 31(10):1662-8. PubMed ID: 2213190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential radiopharmaceuticals for the diagnosis of biliary atresia and neonatal hepatitis: EHPG and HBED chelates of 67Ga and 111In.
    Hunt FC
    Int J Rad Appl Instrum B; 1988; 15(6):659-64. PubMed ID: 3150845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Double Prodrug with Improved Membrane Permeability over the Parent Chelator HBED Provides Superior Cytoprotection against Hydrogen Peroxide.
    Thiele NA; Sloan KB
    ChemMedChem; 2016 Aug; 11(15):1596-9. PubMed ID: 27440560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The identification of 2, 3-dihydroxybenzoic acid as a potentially useful iron-chelating drug.
    Graziano JH; Grady RW; Cerami A
    J Pharmacol Exp Ther; 1974 Sep; 190(3):570-5. PubMed ID: 4416298
    [No Abstract]   [Full Text] [Related]  

  • 19. The development of new iron-chelating drugs. II.
    Grady RW; Graziano JH; White GP; Jacobs A; Cerami A
    J Pharmacol Exp Ther; 1978 Jun; 205(3):575-65. PubMed ID: 660531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced iron removal from liver parenchymal cells in experimental iron overload: liposome encapsulation of HBED and phenobarbital administration.
    Rahman YE; Cerny EA; Lau EH; Carnes BA
    Blood; 1983 Jul; 62(1):209-13. PubMed ID: 6407548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.